AMCHAM India
  • Home
  • About AMCHAM
    • About Us
    • National Executive Board
    • Secretariat
  • Membership
    • Membership
    • Membership Benefits
    • Members Directory
    • Pay Now
  • Committees
  • Events
  • Communication
    • Publications
    • Newsletter Archive
    • Annual Report
    • AMCHAM Press
  • Advocacy
  • Contact
Select Page

AmCham submitted comments on the Proposed Revised Guidelines for Similar Biologics to Drugs Controller General India (DCGI)

May 19, 2016 | Pharma Committee

[vc_row][vc_column][vc_column_text] 

 

These recommendations were submitted by AmCham Pharma Committee to Drugs Controller General India (DCGI) on 26th April 2016.[/vc_column_text][/vc_column][/vc_row]

Copyrights 2021 - 2022. The American Chamber of Commerce In India. Designed & Developed by PixelVJ